|
Volumn 48, Issue 11, 2008, Pages 1366-1367
|
Body weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59-7939) in healthy subjects (Journal of Clinical Pharmacology (February 2007) 47:2 (218-226) DOI: 10.1177/0091270006296058)
a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ERRATUM;
ERROR;
|
EID: 54049092900
PISSN: 00912700
EISSN: 15524604
Source Type: Journal
DOI: 10.1177/0091270008323722 Document Type: Erratum |
Times cited : (3)
|
References (0)
|